Vanberra Signal

BioPharmics

Curated by Signal

Provider of an AI-based drug designing and modeling tool for researchers and scientists

Overview

Provider of an AI-based drug designing and modeling tool for researchers and scientists. The company has developed a computational tool called Surflex that assists in drug based modeling in 3D and 3D structures for drug discovery. The platform assists in modular docking, ligand formation, binding affinity prediction, and more. The tool has features for small molecule processing, pose prediction, and ligand alignment, The Surflex software is composed of five modules for tools, similarity, docking, xGen, and affinity.

Key facts

Founded
1998

Business model

Contact

More on Vanberra Signal

Members only

Competitors & similar companies

More Health Technology companies
  • Offers a point of care dispensing service and software to the clinics

    Health TechnologyBurbank, United States
  • Online platform for healthcare nurse jobs

    Health TechnologyChicago, United States
  • Storage, management and analysis of omic data for health applications

    Health TechnologyIndianapolis, United States

About BioPharmics

What does BioPharmics do?

Provider of an AI-based drug designing and modeling tool for researchers and scientists.

Where is BioPharmics headquartered?

BioPharmics is headquartered in Santa Rosa, United States.

When was BioPharmics founded?

BioPharmics was founded in 1998.

Which sector is BioPharmics in?

BioPharmics operates in Health Technology.

Who are BioPharmics's competitors?

Companies similar to BioPharmics include BRPpharma, Para, and LifeOmic.